Cargando…
Treatment of Severe Immune Thrombocytopenic Purpura Associated with COVID-19
Patient: Female, 48-year-old Final Diagnosis: COVID 19 infection • severe idiopathic thrombocytopenic purpura Symptoms: Bruising • headcahe • hemoptysis • nausea Medication: — Clinical Procedure: — Specialty: Hematology • Infectious Diseases OBJECTIVE: Rare coexistence of disease or pathology BACKGR...
Autores principales: | Ahmed, Nayab, Asreb, Abdullah, Chofor, Rosemary, Melese, Achenef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546270/ https://www.ncbi.nlm.nih.gov/pubmed/34671000 http://dx.doi.org/10.12659/AJCR.932557 |
Ejemplares similares
-
COVID-19 Vaccination Associated Severe Immune Thrombocytopenic Purpura
por: Sharawi, Said, et al.
Publicado: (2022) -
Severe immune thrombocytopenic purpura in critical COVID-19
por: Lévesque, Valérie, et al.
Publicado: (2020) -
Immune thrombocytopenic purpura worsened by COVID-19
por: Kim, Chul Soo, et al.
Publicado: (2021) -
Immune Thrombocytopenic Purpura in Patients with COVID-19
por: Revuz, Sabine, et al.
Publicado: (2020) -
Immune thrombocytopenic purpura and COVID-19 vaccination
por: Joob, Beuy, et al.
Publicado: (2023)